Ryan Pruchnic
Director/Board Member at LIPELLA PHARMACEUTICALS INC.
Net worth: - $ as of 2024-04-29
Profile
Ryan Pruchnic has worked as an Independent Director at Lipella Pharmaceuticals, Inc. since 2021 and as a Managing Vice President at Cook MyoSite, Inc. since 2001.
He has an undergraduate and graduate degree from the University of Pittsburgh.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-14 | 0 ( -.--% ) | - $ | 2024-04-29 |
Ryan Pruchnic active positions
| Companies | Position | Start |
|---|---|---|
| LIPELLA PHARMACEUTICALS INC. | Director/Board Member | 2021-08-31 |
Cook MyoSite, Inc.
 Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Corporate Officer/Principal | 2000-12-31 |
Training of Ryan Pruchnic
| University of Pittsburgh | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIPELLA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Cook MyoSite, Inc.
Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Technology Services |
- Stock Market
- Insiders
- Ryan Pruchnic
